Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1or BRCA2mutations and recurrent ovarian cancer: a proof-of-concept trial
- Resource Type
- Article
- Source
- The Lancet; July 2010, Vol. 376 Issue: 9737 p245-251, 7p
- Subject
- Language
- ISSN
- 01406736; 1474547X